PUNE, India, April 18, 2016 /PRNewswire-iReach/ -- Top Companies Participating in Asthma Therapeutics Clinical Trials
Photo - http://photos.prnewswire.com/prnh/20160418/356306LOGO
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Complete research report of 1725 pages with TOC is available at http://www.reportsnreports.com/reports/528493-asthma-global-clinical-trials-review-h1-2016.html
Scope
Reasons to buy
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE ReportsnReports
Advertisement
Photo - http://photos.prnewswire.com/prnh/20160418/356306LOGO
- AstraZeneca Plc
- GlaxoSmithKline Plc
- Novartis AG
- Merck & Co., Inc.
- C. H. Boehringer Sohn AG & Co. KG
- Teva Pharmaceutical Industries Limited
- F. Hoffmann-La Roche Ltd.
- Chiesi Farmaceutici SpA
- Pfizer Inc.
- Takeda Pharmaceutical Company Limited
Advertisement
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Complete research report of 1725 pages with TOC is available at http://www.reportsnreports.com/reports/528493-asthma-global-clinical-trials-review-h1-2016.html
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE ReportsnReports